<div class="white-sheet">
	<div class="content-slide">

		<div class="title-bar red"></div>

		<div class="wrapper slide-sa">

			<div class="slide-title red">
				Self-assessment
			</div>


			<div class="content-container">
				<!-- <div class="inhibitNavigationSwipe disable-sa"></div> -->
			
				<div class="swipe inhibitNavigationSwipe" id="slider">
				    <div class="swipe-wipe">

				        <div>

				        	<div class="question">
				        		<h2>Question 1</h2>

					        	<p>Which of the following statements correctly describes aplastic anaemia? </p>

					        	<div class="answers" data-question="one">
					        		<button class="answer">A. It is a common disorder</button>

						        	<button class="answer">B. The incidence of aplastic anaemia in Western countries is 2–3 times higher than in Eastern countries</button>

						        	<button class="answer correct">C. 70% of cases are idiopathic (i.e. the primary cause is unknown)</button>

						        	<button class="answer">D. Aplastic anaemia predominantly affects women</button>
					        	</div>

				        	</div>

				        	<!-- <button class="submit blue-button" data-question="one">SUBMIT</button> -->
				        	
				        </div>


				        <div>
				        	
							<div class="question">
				        		<h2>Question 2</h2>

					        	<p>What proportion of bone marrow failure syndromes are inherited?</p>

					        	<div class="answers" data-question="two">
					        		<button class="answer correct">A. 15–20%</button>

						        	<button class="answer">B. 10–15%</button>

						        	<button class="answer">C. More than 70%</button>

						        	<button class="answer">D. 15%</button>
					        	</div>

				        	</div>

				        	<!-- <button class="submit blue-button" data-question="two">SUBMIT</button> -->

				        </div>

				        
				         <div>
				        	
							<div class="question">
				        		<h2>Question 3</h2>

					        	<p>Aplastic anaemia is characterised by: </p>

					        	<div class="answers" data-question="three">
					        		<button class="answer">A. Reduced numbers of red blood cells</button>

						        	<button class="answer correct">B. Pancytopenia and hypocellular bone marrow in the absence of abnormal infiltration or increased reticulin</button>

						        	<button class="answer">C. Pancytopenia and hypocellular bone marrow with abnormal infiltration and increased reticulin</button>

						        	<button class="answer">D. Hypercellular bone marrow</button>
					        	</div>

				        	</div>

				        	<!-- <button class="submit blue-button" data-question="three">SUBMIT</button> -->

				        </div>

				        <div>
				        	
							<div class="question">
				        		<h2>Question 4</h2>

					        	<p>What level of bone marrow cellularity is used to define severe aplastic anaemia?</p>

					        	<div class="answers" data-question="four">
					        		<button class="answer">A. 10% of the normal control</button>

						        	<button class="answer">B. &lt;25% of the normal control with &lt;30% residual HSCs</button>

						        	<button class="answer">C. 25–50% of the normal control with &lt;25% residual HSCs</button>

						        	<button class="answer correct">D. 25% of the normal control or 25–50% with &lt;30% residual HSCs </button>
					        	</div>

				        	</div>

				        	<!-- <button class="submit blue-button" data-question="four">SUBMIT</button> -->

				        </div>

				        <div>
				        	
							<div class="question">
				        		<h2 style="margin-bottom:10px">Question 5</h2>

					        	<p style="margin:0 0 10px">How many of the peripheral blood criteria for cytopenia (i.e. neutrophil count: &lt;0.5×10<sup>9</sup>/l; platelet count: &lt;20×10<sup>9</sup>/l and reticulocyte count: &lt;20×10<sup>9</sup>/l) are used to define severe aplastic anaemia?</p>

					        	<div class="answers" data-question="five">
					        		<button class="answer">A. None, only bone marrow cellularity is assessed</button>

						        	<button class="answer">B. One</button>

						        	<button class="answer correct">C. Two</button>

						        	<button class="answer">D. Three</button>
					        	</div>

				        	</div>

				        	<!-- <button class="submit blue-button" data-question="five">SUBMIT</button> -->

				        </div>

				        <div>
				        	
							<div class="question">
				        		<h2>Question 6</h2>

					        	<p>Inherited aplastic anaemia suggested by:</p>

					        	<div class="answers" data-question="six">
					        		<button class="answer correct">A. Skin and nail changes, skeletal abnormalities or young onset of cancer, with aplastic anaemia</button>

						        	<button class="answer">B. Stunted growth only</button>

						        	<button class="answer">C. Skin and nail changes, skeletal abnormalities or atypically young onset of cancer, but no pancytopenia</button>

						        	<button class="answer">D. First diagnosis of aplastic anaemia in adulthood, with no prior history during childhood</button>
					        	</div>

				        	</div>

				        	<!-- <button class="submit blue-button" data-question="six">SUBMIT</button> -->

				        </div>

				        <div>
				        	
							<div class="question">
				        		<h2>Question 7</h2>

					        	<p>In addition to symptoms of anaemia (e.g. fatigue), patients with aplastic anaemia often present with:</p>

					        	<div class="answers" data-question="seven">
					        		<button class="answer">A. Mouth ulcers</button>

						        	<button class="answer">B. No other symptoms, hence the delay in diagnosis</button>

						        	<button class="answer">C. Fever, due to infection</button>

						        	<button class="answer correct">D. Bruising</button>
					        	</div>

				        	</div>

				        	<!-- <button class="submit blue-button" data-question="seven">SUBMIT</button> -->

				        </div>

				        <div>
				        	
							<div class="question">
				        		<h2>Question 8</h2>

					        	<p>What observation supports immune pathophysiology in acquired aplastic anaemia?</p>

					        	<div class="answers" data-question="eight">
					        		<button class="answer correct">A. Restoration of blood counts to healthy levels after ciclosporin and or ATG administration</button>

						        	<button class="answer">B. Identification of autoantibodies against cells expressing TPO receptors</button>

						        	<button class="answer">C. Restoration of blood counts to healthy levels after cyclophosphamide administration</button>

						        	<button class="answer">D. Improvement after administration of high-dose ciclosporin</button>
					        	</div>

				        	</div>

				        	<!-- <button class="submit blue-button" data-question="eight">SUBMIT</button> -->

				        </div>

				        <div>
				        	
							<div class="question">
				        		<h2>Question 9</h2>

					        	<p>The cytotoxic T-cell immune response is directed at HSCs and progenitor cells that express:</p>

					        	<div class="answers" data-question="nine">
					        		<button class="answer">A. CD8 antigen</button>

						        	<button class="answer correct">B. CD34 antigen</button>

						        	<button class="answer">C. TPO receptors</button>

						        	<button class="answer">D. EPO receptors</button>
					        	</div>

				        	</div>

				        	<!-- <button class="submit blue-button" data-question="nine">SUBMIT</button> -->

				        </div>

				        <div>
				        	
							<div class="question">
				        		<h2>Question 10</h2>

					        	<p>In 10–15% of patients with severe aplastic anaemia, the disease may evolve to:</p>

					        	<div class="answers" data-question="ten">
					        		<button class="answer">A. Myelodysplasia</button>

						        	<button class="answer">B. Myelodysplasia or leukaemia</button>

						        	<button class="answer">C. Leukaemia</button>

						        	<button class="answer correct">D. Paroxysmal nocturnal haemoglobinuria, leukaemia or myelodysplasia</button>
					        	</div>

				        	</div>

				        	<!-- <button class="submit blue-button" data-question="ten">SUBMIT</button> -->

				        </div>


				         <div>
				        	
							<div class="question">
				        		<h2>Question 11</h2>

					        	<p>If bone marrow fragments are difficult to obtain from an aspirate, this suggests that:</p>

					        	<div class="answers" data-question="eleven">
					        		<button class="answer">A. The patient has acquired aplastic anaemia</button>

						        	<button class="answer">B. The patient has an inherited bone marrow failure syndrome</button>

						        	<button class="answer correct">C. The patient may have a condition other than aplastic anaemia</button>

						        	<button class="answer">D. The patient has a skeletal disorder</button>
					        	</div>

				        	</div>

				        	<!-- <button class="submit blue-button" data-question="eleven">SUBMIT</button> -->

				        </div>


				         <div>
				        	
							<div class="question">
				        		<h2>Question 12</h2>

					        	<p>Which innovations have proven useful in excluding other conditions that cause pancytopenia?</p>

					        	<div class="answers" data-question="twelve">
					        		<button class="answer">A. Genetic testing only</button>

						        	<button class="answer correct">B. Cytogenic, genetic, serological testing, diagnostic algorithms and sensitive assays for clonal disorders</button>

						        	<button class="answer">C. Serological and genetic testing</button>

						        	<button class="answer">D. Sensitive assays for clonal disorders, cytogenic studies and diagnostic algorithms</button>
					        	</div>

				        	</div>

				        	<!-- <button class="submit blue-button" data-question="twelve">SUBMIT</button> -->

				        </div>


				         <div>
				        	
							<div class="question">
				        		<h2>Question 13</h2>

					        	<p>In the treatment of severe aplastic anaemia, supportive strategies may include:</p>

					        	<div class="answers" data-question="thirteen">
					        		<button class="answer correct">A. Transfusion of blood products, administration of prophylactic antibiotics and treatment with growth factors</button>

						        	<button class="answer">B. Treatment with growth factors only </button>

						        	<button class="answer">C. G-CSF and antibiotics together</button>

						        	<button class="answer">D. HSCT</button>
					        	</div>

				        	</div>

				        	<!-- <button class="submit blue-button" data-question="thirteen">SUBMIT</button>
 -->
				        </div>


				         <div>
				        	
							<div class="question">
				        		<h2>Question 14</h2>

					        	<p>To date, the only potentially curative treatment for severe aplastic anaemia is:</p>

					        	<div class="answers" data-question="fourteen">
					        		<button class="answer">A. Immunosuppressive therapy</button>

						        	<button class="answer">B. Anabolic/low-dose steroids</button>

						        	<button class="answer correct">C. HSCT</button>

						        	<button class="answer">D. Platelet transfusion</button>
					        	</div>

				        	</div>

				        	<!-- <button class="submit blue-button" data-question="fourteen">SUBMIT</button>
 -->
				        </div>


				         <div>
				        	
							<div class="question">
				        		<h2>Question 15</h2>

					        	<p>If successful, HSCT is associated with a survival of:</p>

					        	<div class="answers" data-question="fifteen">
					        		<button class="answer">A. ~50–60% for patients aged under 40 years</button>

						        	<button class="answer correct">B. Over 70% for patients aged 40 years and under</button>

						        	<button class="answer">C. Over 70% for all patients, regardless of age</button>

						        	<button class="answer">D. Less than 50% for any patient</button>
					        	</div>

				        	</div>

				        	<!-- <button class="submit blue-button" data-question="fifteen">SUBMIT</button> -->

				        </div>


				         <div>
				        	
							<div class="question">
				        		<h2>Question 16</h2>

					        	<p>IST is the first line of definitive treatment for severe aplastic anaemia patients who:</p>

					        	<div class="answers" data-question="sixteen">
					        		<button class="answer">A. Lack a matched sibling donor</button>

						        	<button class="answer">B. Are medically unfit for transplant</button>

						        	<button class="answer">C. Are over the age of 30</button>

						        	<button class="answer correct">D. Lack a matched sibling donor or may not be good candidates for transplant</button>
					        	</div>

				        	</div>

				        	<!-- <button class="submit blue-button" data-question="sixteen">SUBMIT</button> -->

				        </div>


				        <div>
				        	
							<div class="question">
				        		<h2>Question 17</h2>

					        	<p>What does the standard immunosuppressive regimen consist of, depending on availability of the agents in your region?</p>

					        	<div class="answers" data-question="seventeen">
					        		<button class="answer correct">A. h-ATG and ciclosporin</button>

						        	<button class="answer">B. r-ATG and ciclosporin</button>

						        	<button class="answer">C. h-ATG, ciclosporin and fludarabine</button>

						        	<button class="answer">D. r-ATG, ciclosporin and alemtuzumab</button>
					        	</div>

				        	</div>

				        	<!-- <button class="submit blue-button" data-question="seventeen">SUBMIT</button> -->

				        </div>


				        <div>
				        	
							<div class="question">
				        		<h2>Question 18</h2>

					        	<p>r-ATG was initially found to be effective in:</p>

					        	<div class="answers" data-question="eighteen">
					        		<button class="answer">A. Severe aplastic anaemia patients who were intolerant to h-ATG</button>

						        	<button class="answer correct">B. Refractory or relapsed severe aplastic anaemia patients</button>

						        	<button class="answer">C. Refractory aplastic anaemia patients</button>

						        	<button class="answer">D. Relapsed aplastic anaemia patients</button>
					        	</div>

				        	</div>

				        	<!-- <button class="submit blue-button" data-question="eighteen">SUBMIT</button> -->

				        	

				        </div>


				        <div>
				        	
							<div class="question">
				        		<h2>Question 19</h2>

					        	<p>How is relapse defined in severe aplastic anaemia?</p>

					        	<div class="answers" data-question="nineteen">
					        		<button class="answer correct">A. There is no consensus on the definition of relapse</button>

						        	<button class="answer">B. Decreased blood count despite 6 months of blood product transfusion</button>

						        	<button class="answer">C. Deterioration of neutrophil count to &lt;0.2×10<sup>9</sup>/l</button>

						        	<button class="answer">D. Deterioration of neutrophil count to &lt;0.5×10<sup>9</sup>/l and reticulocyte count to &lt;20×10<sup>9</sup>/l</button>
					        	</div>

				        	</div>

				        	<!-- <button class="submit blue-button" data-question="eighteen">SUBMIT</button> -->

				        	

				        </div>


				        <div>
				        	
							<div class="question">
				        		<h2>Question 20</h2>

					        	<p>Treatment of relapsed severe aplastic anaemia with IST should continue:</p>

					        	<div class="answers" data-question="twenty">
					        		<button class="answer">A. For 6 months</button>

						        	<button class="answer">B. For a year, maximum</button>

						        	<button class="answer">C. Until the patient shows improvements in blood counts and symptoms</button>

						        	<button class="answer correct">D. For at least 6–12 months</button>
					        	</div>

				        	</div>

				        	<!-- <button class="submit blue-button" data-question="eighteen">SUBMIT</button> -->

				        	

				        </div>


				        <div>
				        	
							<div class="question">
				        		<h2>Question 21</h2>

					        	<p>The rate of response to r-ATG for the treatment of refractory severe aplastic anaemia is:</p>

					        	<div class="answers" data-question="twentyOne">
					        		<button class="answer">A. 37%</button>

						        	<button class="answer correct">B. 27–77%</button>

						        	<button class="answer">C. 27%</button>

						        	<button class="answer">D. 27–33%</button>
					        	</div>

				        	</div>

				        	<!-- <button class="submit blue-button" data-question="eighteen">SUBMIT</button> -->

				        	

				        </div>


				        <div>
				        	
							<div class="question">
				        		<h2>Question 22</h2>

					        	<p>In refractory severe aplastic anaemia, when should HSCT be considered?</p>

					        	<div class="answers" data-question="twentyTwo">
					        		<button class="answer">A. If pancytopenia persists after 12 months</button>

						        	<button class="answer">B. If pancytopenia worsens within the first 4 months of repeated IST</button>

						        	<button class="answer correct">C. If pancytopenia persists 6 months after IST</button>

						        	<button class="answer">D. If the patient is willing to receive a transplant from an unrelated donor</button>
					        	</div>

				        	</div>

				        	<!-- <button class="submit blue-button" data-question="eighteen">SUBMIT</button> -->

				        	

				        </div>


				        <div>
				        	
							<div class="question">
				        		<h2>Question 23</h2>

					        	<p>What type of HSC donor is considered first choice in all patients?</p>

					        	<div class="answers" data-question="twentyThree">
					        		<button class="answer correct">A. Matched sibling donor</button>

						        	<button class="answer">B. Unrelated donor</button>

						        	<button class="answer">C. Haploidentical donor</button>

						        	<button class="answer">D. Umbilical cord donor</button>
					        	</div>

				        	</div>

				        	<!-- <button class="submit blue-button" data-question="eighteen">SUBMIT</button> -->

				        	

				        </div>


				        <div>
				        	
							<div class="question">
				        		<h2>Question 24</h2>

					        	<p>Survival rates associated with unrelated donor transplant are:</p>

					        	<div class="answers" data-question="twentyFour">
					        		<button class="answer">A. On par with matched sibling donor transplant for patients of any age</button>

						        	<button class="answer correct">B. More variable than those associated with matched sibling donor transplant and may not be as high</button>

						        	<button class="answer">C. Higher than those associated with matched sibling donor transplant</button>

						        	<button class="answer">D. Consistently lower than those associated with matched sibling donor transplant</button>
					        	</div>

				        	</div>

				        	<!-- <button class="submit blue-button" data-question="eighteen">SUBMIT</button> -->

				        	

				        </div>


				        <div>
				        	
							<div class="question">
				        		<h2>Question 25</h2>

					        	<p>Which of the following is not a potential cause of morbidity or mortality in severe aplastic anaemia?</p>

					        	<div class="answers" data-question="twentyFive">
					        		<button class="answer">A. Graft failure</button>

						        	<button class="answer">B. Interstitial pneumonia</button>

						        	<button class="answer">C. Haemorrhage</button>

						        	<button class="answer correct">D. Renal failure</button>
					        	</div>

				        	</div>

				        	<!-- <button class="submit blue-button" data-question="eighteen">SUBMIT</button> -->

				        	

				        </div>

				         <div class="summary-section-1">
				        	
							<div class="summary-section">
				        		<h2>Summary</h2>

				        		<button class="submit blue-button show-results">SHOW RESULTS</button>

					        	<button class="submit blue-button navigate" data-navtarget="slide_sa_2">RETAKE ASSESSMENT</button>

					        	<button class="submit blue-button navigate" data-navtarget="mod_2_home">RESTART MODULE</button>

					        	<div class="mod-results">
					        		<p>you scored <span></span> out of 25</p>

						        	<!-- <ul>
						        		
						        	</ul>
						        	<ul>
						        		
						        	</ul> -->

						        	<div class="results-table">
						        		
										<table>
											
										</table>

						        	</div>
					        	</div>

				        	</div>

				        	
				        	

				        </div>

				    </div>
				</div>

				<button class="swipe-next" style="float:right;"></button>
				<button class="swipe-prev"></button>

			</div>

		</div>

	</div>
</div>
<script>
	addInviewFunction(function () { 

        $('.question button').on('click tap',function(){

        	$(this).parent().children().removeClass('active');

        	$(this).addClass('active')

        	var questionNo = $(this).parent().attr('data-question');

        	var correct = $(this).hasClass('correct');

        	// for question no : correct or incorrect inside ul

        	// if(correct){
        	// 	questions[questionNo] = 'Correct';
        	// }else{
        	// 	questions[questionNo] = 'Incorrect';	
        	// }

        	//for question correct or incorrect inside table

        	if(correct){
        		questions[questionNo] = {};
        		questions[questionNo].status = 'Correct';
        		questions[questionNo].question = $(this).parent().prev().html();

        	}else{
        		questions[questionNo] = {};
        		questions[questionNo].status = 'Inorrect';
        		questions[questionNo].question = $(this).parent().prev().html();	
        	}
  
        });



        window.questions = {};

        var score = '0';

		
		$('.summary-section-1 .show-results').on('click tap',function(){
			console.log('show results');

		// for question no : correct or incorrect inside ul
			// if($('.summary-section ul li').length=== 0){

			// 	var count = 0;
			// 	for(key in questions){
		 //        	var val = questions[key];
		 //        	count++;
		 //        	// $('.summary-section ul').append('<li>Question '+key+': '+val+'</li>');

		 //        	if(count < 10){
		 //        		if (val === 'Correct') {
			//         		score++;
			//         		$('.summary-section ul:eq(0)').append('<li>Question '+key+': <span class="correct">'+val+'</span></li>');
			//         	}else{
			//         		$('.summary-section ul:eq(0)').append('<li>Question '+key+': <span class="incorrect">'+val+'</span></li>');
			//         	};
		 //        	}else{
		 //        		if (val === 'Correct') {
			//         		score++;
			//         		$('.summary-section ul:eq(1)').append('<li>Question '+key+': <span class="correct">'+val+'</span></li>');
			//         	}else{
			//         		$('.summary-section ul:eq(1)').append('<li>Question '+key+': <span class="incorrect">'+val+'</span></li>');
			//         	};
		 //        	}

		        	

		 //        }

		 //        $('.summary-section p span').html(score);

		 //        $('.mod-results').fadeIn(); 

		 //        $('.question .answers button').attr('disabled','true'); 

			// }

			if($('.summary-section table tr').length===0){

				for (key in questions){

					var obj = questions[key];

					if(obj.status === 'Correct'){
						score++;
						$('.summary-section table').append("<tr><td>"+obj.question+"</td><td class='correct'>Correct</td></tr>");
					}else{
						$('.summary-section table').append("<tr><td>"+obj.question+"</td><td class='incorrect'>Incorrect</td></tr>");
					}

				}


				$('.summary-section p span').html(score);

		        $('.mod-results').fadeIn(); 

		        $('.question .answers button').attr('disabled','true'); 

			}
			

		});



        

        
    });
</script>